The Vanguard Group 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:16 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | The Vanguard Group | 3,381,368 7.140% | -835,703 (-19.82%) | Filing |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | The Vanguard Group | 4,217,071 9.010% | -20,420 (-0.48%) | Filing |
| 2020-02-12 08:02 am Purchase | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | The Vanguard Group | 4,237,491 9.140% | 201,054 (+4.98%) | Filing |